Novartis Investigative Site

Krakow, Poland 31-531

1 studies enrolling now · 4 studies all time

What they study most

Acute Decompensated Heart Failure, Amyotrophic Lateral Sclerosis (ALS), Congestive Heart Failure, Coronary Artery Disease (CAD), Coronary Atherosclerosis, Secondary Progressive Multiple Sclerosis (SPMS)

Studies at this site

• A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis — Recruiting now
• A Clinical Trial to Learn About the Effects of VHB937 in People With Amyotrophic Lateral Sclerosis (ALS) — Running, not enrolling
• Safety and Efficacy of Aliskiren on the Progression of Atherosclerosis in Coronary Artery Disease Patients — Completed
• Six Months Efficacy and Safety of Aliskiren Therapy on Top of Standard Therapy, on Morbidity and Mortality in Patients With Acute Decompensated Heart Failure — Completed